|
Targeting the ATP/P2X7R axis to prevent and treat type 1 diabetes, allograft rejection, lung fibrosis and aging
Targeting the ATP/P2X7R axis to prevent and treat type 1 diabetes, allograft rejection, lung fibrosis and aging
Background
Insulin therapy, the current standard treatment for type 1 diabetes (T1D) cannot fully prevent the severe complications related to the disease which include kidney failure and coronary heart disease. Successful islet transplantation...
Published: 3/6/2026
|
Updated: 4/11/2025
|
Inventor(s):
Keywords(s):
Category(s): Technology Classifications > Disease Area > Autoimmune, Technology Classifications > Disease Area > Immunology, Technology Classifications > Disease Area > Transplant, Technology Classifications > Invention Type > Therapeutics, Technology Classifications > Invention Type > Therapeutics > Small Molecule
|
